Nurse Practitioner in Falls City, NE Accepting Medicare

8 Nurse Practitioner nurses found. Showing 1 - 8

Amanda C Sipple, NP Nurse Practitioner - Women's Health Medicare: Not Enrolled in Medicare Practice Location: 116 W 19th St, Falls City, NE 68355 Phone: 402-245-4655

Danelle Alyce Goltz, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3110 Mclean St, Falls City, NE 68355 Phone: 402-245-8650

Alexis Stallbaumer, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 3307 Barada St, Falls City, NE 68355 Phone: 402-245-2428

Kylee Rae Meyer, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3307 Barada St, Falls City, NE 68355 Phone: 402-246-6545    Fax: 402-245-6640

Sandra Sue Catlin, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3307 Barada St, Falls City, NE 68355 Phone: 402-245-4475    Fax: 402-245-6651

Gayle Lynette Keller, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3307 Barada St, Falls City, NE 68355 Phone: 402-245-4475    Fax: 402-245-6651

Amy Reafleng, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 3307 Barada St, Falls City, NE 68355 Phone: 402-245-2428

Laura A Harmon, APRN-NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3307 Barada St, Falls City, NE 68355 Phone: 402-245-2428

News Archive

Midwest Employers Casualty Company introduces Safety Cornerstones Express program for Self-Insured Groups

Midwest Employers Casualty Company (MECC), the leading workers' compensation excess insurance company that helps clients to manage their Total Cost of Risk, today announced the unveiling of its Safety Cornerstones Express program to Self-Insured Groups (SIGs).

New research assesses nanomedicine-based approaches for treating cancer

As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.

UAB research explores neurofibromatosis type 1

It is easy to tell a medical research story that has a simple and dramatic moment. But disease is often much more complex, and the work to understand it can be painstaking. A vivid example of that is seen in the University of Alabama at Birmingham Medical Genomics Laboratory, headed by Ludwine Messiaen, Ph.D., professor of genetics. This lab offers clinical genetic testing for a broad array of common and rare genetic disorders.

New kirigami-inspired method to create wearable sensors

As wearable sensors become more prevalent, the need for a material resistant to damage from the stress and strains of the human body's natural movement becomes ever more crucial.

FDA grants Impax final approval for generic Allegra-D ANDA

Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.

Read more Medical News

› Verified 9 days ago